3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Vision Disorders
1
Pituitary Neoplasms
1
Mediastinal Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Glioma
1
Breast Neoplasms
1
Interventions
Rituximab
55
Cyclophosphamide
38
Vincristine
25
Prednisone
24
Doxorubicin
21
Cytarabine
18
Etoposide
17
Lenalidomide
16
Gemcitabine
12
Melphalan
8
Filgrastim
8
Cisplatin
8
Peripheral Blood Stem Cell Transplantation
7
Oxaliplatin
7
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
7
Methotrexate
7
Ifosfamide
7
Carmustine
7
zanubrutinib
6
R-CHOP protocol
6
Vindesine
5
Radiotherapy
5
Dexamethasone
5
Busulfan
5
ibrutinib
4
fludarabine phosphate
4
Methylprednisolone
4
Epirubicin
4
Decitabine
4
Cyclosporine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Large B-Cell, Diffuse
×
Diffusion Tensor Imaging
×
Clear all
NCT03121456
2023-11-13
LYMPHODTECT
Centre Antoine Lacassagne
Phase NA
Unknown
74 enrolled